Surface Oncology Inc reports results for the quarter ended in March - Earnings Summary

Surface Oncology

08/05/2023 14:32

* Surface Oncology Inc  SURF.OQ  reported a quarterly
adjusted
loss of 33 cents​​ per share for the quarter ended in March. The
mean expectation of four analysts for the quarter was for a loss
of 36 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Surface Oncology Inc's reported EPS for the quarter was a
loss
of 33 cents​.
    * The mean earnings estimate of analysts had risen by
about 7.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Surface Oncology Inc shares had fallen by 14.7% this
quarter and
lost 27.3% so far this year.
    * The company reported a quarterly loss of $19.74 million.
    * Wall Street's median 12-month price target for Surface
Oncology
Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
8 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.36          -0.33          Beat
 Dec. 31 2022      -0.33          -0.35          Missed
 Sep. 30 2022      -0.47          -0.39          Beat
 Jun. 30 2022      -0.46          -0.46          Met